Pulmonary Hypertension in Patients With Myeloproliferative Neoplasms
This is an observational prospective study aiming to clarify the prevalence of pulmonary hypertension in patients with Myeloproliferative Neoplasms and their prognosis.

All patients attending our department with the above mentioned neoplasms will be offered inclusion in this study. All will have an echo performed and patients identified as being at risk of pulmonary hypertension will be offered complete investigation as specified by the European Cardiology Association.

All patients will be followed up for a total of five years to identify prognosis.
Myeloproliferative Disorders|Pulmonary Hypertension
RADIATION: Radiology
Prevalence of pulmonary hypertension at initial presentation and first echo, Initial recruitment
Mortality, 1 and 5 years|Incidence of pulmonary hypertension while under follow-up, 5 years
This is an observational prospective study aiming to clarify the prevalence of pulmonary hypertension in patients with Myeloproliferative Neoplasms and their prognosis.

All patients attending our department with the above mentioned neoplasms will be offered inclusion in this study. All will have an echo performed and patients identified as being at risk of pulmonary hypertension will be offered complete investigation as specified by the European Cardiology Association.

All patients will be followed up for a total of five years to identify prognosis.